← Back to headlines
Novo Nordisk Seeks US Market Comeback for Weight-Loss Drugs
Novo Nordisk, maker of Wegovy and Ozempic, is strategizing a comeback in the US market for its weight-loss drugs, aiming to learn from consumer groups to improve its approach.
13 Apr, 04:00 — 13 Apr, 04:00
Sources
Showing 1 of 1 sources


